Oct 29, 2017 - The market for psoriasis drugs has never been more competitive, and that's boosting risk for investors.
Oct 24, 2017 - A Slew Of Q3 Earnings
Oct 24, 2017 - Most major companies reporting before the opening bell today have outperformed expectations -- in some cases by a wide margin.
Oct 18, 2017 - There's more good news than you might think.
Oct 17, 2017 - Despite a strong earnings beat, not everything went J&J's way in the third quarter.
Oct 06, 2017 - Lilly (LLY) has received a favorable ruling from the U.S. PTO in a dispute related to vitamin regimen patent on its key cancer drug, Alimta.
Oct 02, 2017 - When the smart money exits a position, it should give you a noodle point about why they're selling.
Sep 29, 2017 - Big pharma companies have thrown hundreds of millions of dollars at this small biotech. Should retail investors follow suit?
Sep 26, 2017 - On Tuesday, shares of biopharmaceutical company Axovant Sciences Ltd. (AXON) have crashed, and the stock is currently down over 70% to $6.72 per share in late-morning trading after it said that its experimental Alzheimer's drug failed a key late-stage trial.
Sep 22, 2017 - Bernstein sees opportunity in a buyout target.